Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank71
Studio
Year-over-Year Change

Return on equity

Latest
-47.83%
↑ 29% vs avg
Percentile
P71
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-67.56%
Historical baseline
PeriodValueYoY Change
2025-47.83%+22.5%
2024-61.76%+33.0%
2023-92.18%+38.4%
2022-149.63%-21.3%
2021-123.32%-46.3%
2020-84.28%-318.2%
2019-20.15%-193.0%
2018-6.88%+59.8%
2017-17.09%+76.4%
2016-72.47%-